HK1202335A1 - 細胞和其它複雜生物材料的色譜分離 - Google Patents
細胞和其它複雜生物材料的色譜分離Info
- Publication number
- HK1202335A1 HK1202335A1 HK15102849.2A HK15102849A HK1202335A1 HK 1202335 A1 HK1202335 A1 HK 1202335A1 HK 15102849 A HK15102849 A HK 15102849A HK 1202335 A1 HK1202335 A1 HK 1202335A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cells
- biological materials
- complex biological
- chromatographic isolation
- chromatographic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70517—CD8
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261602150P | 2012-02-23 | 2012-02-23 | |
PCT/EP2013/053650 WO2013124474A2 (en) | 2012-02-23 | 2013-02-25 | Chromatographic isolation of cells and other complex biological materials |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202335A1 true HK1202335A1 (zh) | 2015-09-25 |
Family
ID=47891608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102849.2A HK1202335A1 (zh) | 2012-02-23 | 2015-03-20 | 細胞和其它複雜生物材料的色譜分離 |
Country Status (11)
Country | Link |
---|---|
US (3) | US10228312B2 (zh) |
EP (1) | EP2817625A2 (zh) |
JP (4) | JP6362543B2 (zh) |
CN (2) | CN106940268B (zh) |
AU (3) | AU2013224027B2 (zh) |
CA (1) | CA2865033C (zh) |
HK (1) | HK1202335A1 (zh) |
IN (1) | IN2014DN06475A (zh) |
RU (1) | RU2746407C1 (zh) |
SG (2) | SG11201404991YA (zh) |
WO (1) | WO2013124474A2 (zh) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9637719B2 (en) | 2013-12-06 | 2017-05-02 | Douglas T. Gjerde | Devices and methods for purification of biological cells |
WO2015154048A1 (en) * | 2014-04-03 | 2015-10-08 | Gjerde Douglas T | Devices and methods for purification, detection and use of biological cells |
AU2013224027B2 (en) | 2012-02-23 | 2019-01-24 | Juno Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
HUE052573T2 (hu) | 2013-12-20 | 2021-05-28 | Hutchinson Fred Cancer Res | Jelölt kiméra effektormolekulák és receptoraik |
EP3132247B1 (en) | 2014-04-16 | 2021-08-18 | Juno Therapeutics GmbH | Methods, kits and apparatus for expanding a population of cells |
SG11201608862SA (en) * | 2014-04-23 | 2016-11-29 | Juno Therapeutics Inc | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy |
WO2015166049A1 (en) | 2014-04-30 | 2015-11-05 | Iba Gmbh | Method of isolating a target cell |
EP2955521A1 (en) * | 2014-06-11 | 2015-12-16 | Centre Hospitalier Universitaire Vaudois (CHUV) | Methods for separating cells |
PL3215601T3 (pl) * | 2014-11-05 | 2020-11-02 | Juno Therapeutics, Inc. | Sposoby transdukcji i przetwarzania komórek |
DE202014105965U1 (de) | 2014-12-10 | 2015-01-26 | Cell.Copedia GmbH | Spritzengehäuse zum Pipettieren eines biologischen Materials mit integrierten Membranen |
WO2016166568A1 (en) | 2015-04-16 | 2016-10-20 | Juno Therapeutics Gmbh | Methods, kits and apparatus for expanding a population of cells |
WO2016176652A2 (en) | 2015-04-29 | 2016-11-03 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
CN105606815A (zh) * | 2015-05-18 | 2016-05-25 | 烟台载通生物技术有限公司 | 一种用于免疫检测的多单元装置 |
CA3002742A1 (en) | 2015-10-22 | 2017-04-27 | Juno Therapeutics Gmbh | Methods, kits, agents and apparatuses for transduction |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
MA45488A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés, kits et appareil de culture de cellules |
GB201521784D0 (en) * | 2015-12-10 | 2016-01-27 | Univ Birmingham | Cell purification |
KR102553195B1 (ko) | 2016-07-29 | 2023-07-07 | 주노 쎄러퓨티크스 인코퍼레이티드 | 항-cd19 항체에 대한 항-이디오타입 항체 |
US10294454B2 (en) | 2016-08-24 | 2019-05-21 | General Electric Company | Methods and kits for cell activation |
KR20190100174A (ko) | 2016-12-23 | 2019-08-28 | 엑소팜 리미티드 | 미세소포 및 엑소좀의 정제 또는 단리를 위한 방법 및 조성물 |
JP2020505034A (ja) | 2017-01-20 | 2020-02-20 | ジュノ セラピューティクス ゲーエムベーハー | 細胞表面コンジュゲートならびに関連する細胞組成物および方法 |
JP7339160B2 (ja) * | 2017-04-27 | 2023-09-05 | ジュノ セラピューティクス ゲーエムベーハー | オリゴマー粒子試薬およびその使用方法 |
KR20200064060A (ko) | 2017-07-29 | 2020-06-05 | 주노 쎄러퓨티크스 인코퍼레이티드 | 재조합 수용체를 발현하는 세포 증폭용 시약 |
MX2020001490A (es) | 2017-08-09 | 2020-08-06 | Juno Therapeutics Inc | Metodos para producir composiciones de celulas geneticamente modificadas y composiciones relacionadas. |
JP2021505168A (ja) | 2017-12-08 | 2021-02-18 | ジュノー セラピューティクス インコーポレイテッド | 操作されたt細胞の組成物を製造するための方法 |
US20200330899A1 (en) * | 2017-12-29 | 2020-10-22 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Purification and labeling of extracellular vesicles using a mixed mode resin composition |
US20210269772A1 (en) * | 2018-07-17 | 2021-09-02 | University Of Washington | Compositions and methods related to aptamer-based reversible cell selection |
EP3833742A2 (en) | 2018-08-09 | 2021-06-16 | Juno Therapeutics, Inc. | Processes for generating engineered cells and compositions thereof |
SG11202102108QA (en) | 2018-09-11 | 2021-04-29 | Juno Therapeutics Inc | Methods for mass spectrometry analysis of engineered cell compositions |
JP2022512872A (ja) | 2018-10-31 | 2022-02-07 | ジュノ セラピューティクス ゲーエムベーハー | 細胞の選択および刺激のための方法ならびにそのための装置 |
WO2020097132A1 (en) | 2018-11-06 | 2020-05-14 | Juno Therapeutics, Inc. | Process for producing genetically engineered t cells |
EP3980530A1 (en) | 2019-06-07 | 2022-04-13 | Juno Therapeutics, Inc. | Automated t cell culture |
KR20220052992A (ko) * | 2019-08-30 | 2022-04-28 | 프로디자인 소닉스, 인크. | 다중 표적 수용체를 위한 음향 친화성 세포 선택 |
CN114600172A (zh) | 2019-08-30 | 2022-06-07 | 朱诺治疗学股份有限公司 | 用于将细胞分类的机器学习方法 |
BR112022008023A2 (pt) | 2019-10-30 | 2022-07-12 | Juno Therapeutics Gmbh | Dispositivos de seleção e/ou estimulação de células e métodos de uso |
WO2021118873A1 (en) * | 2019-12-09 | 2021-06-17 | St. Jude Children's Research Hospital, Inc. | Method for preparing cd7-negative, cd3-positive t cells |
CN115427550A (zh) | 2020-01-28 | 2022-12-02 | 朱诺治疗学股份有限公司 | T细胞转导方法 |
EP4180811A1 (en) | 2020-01-31 | 2023-05-17 | Cell.copedia GmbH | Methods of isolating a biological entity |
AU2021219764A1 (en) | 2020-02-12 | 2022-09-01 | Juno Therapeutics, Inc. | BCMA-directed chimeric antigen receptor T cell compositions and methods and uses thereof |
IL295384A (en) | 2020-02-12 | 2022-10-01 | Juno Therapeutics Inc | Preparations of t cells with a chimeric antigen receptor directed against cd19 and methods and uses thereof |
WO2021231661A2 (en) | 2020-05-13 | 2021-11-18 | Juno Therapeutics, Inc. | Process for producing donor-batched cells expressing a recombinant receptor |
WO2022234009A2 (en) | 2021-05-06 | 2022-11-10 | Juno Therapeutics Gmbh | Methods for stimulating and transducing t cells |
WO2023017115A1 (en) | 2021-08-11 | 2023-02-16 | Iba Lifesciences Gmbh | Fractionation of cells based on a marker protein |
CN113908589B (zh) * | 2021-10-08 | 2022-09-27 | 天津工业大学 | 一种表面印迹抗体的疏水电荷诱导模式膜层析介质及其制备方法 |
WO2023147510A1 (en) | 2022-01-28 | 2023-08-03 | Juno Therapeutics, Inc. | Chromatography arrays and related methods and kits |
EP4223381A1 (en) * | 2022-02-02 | 2023-08-09 | Sartorius BIA Separations d.o.o. | Method of purifying or removing a target component from full plasma |
WO2023213969A1 (en) | 2022-05-05 | 2023-11-09 | Juno Therapeutics Gmbh | Viral-binding protein and related reagents, articles, and methods of use |
WO2023230581A1 (en) | 2022-05-25 | 2023-11-30 | Celgene Corporation | Methods of manufacturing t cell therapies |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2624470B2 (ja) | 1984-10-02 | 1997-06-25 | バイオジェン インコーポレイテッド | ストレプトアビジン様ポリペプチドの製造 |
US4851341A (en) | 1986-12-19 | 1989-07-25 | Immunex Corporation | Immunoaffinity purification system |
DE4237113B4 (de) | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
WO1996023879A1 (en) | 1995-01-30 | 1996-08-08 | Terrapin Technologies, Inc. | Glubodies - multiplicities of proteins capable of binding a variety of small molecules |
EP0815121A4 (en) | 1995-02-09 | 1999-09-01 | Univ Washington | MODIFIED AFFINITY STREPTAVIDINE |
US6022951A (en) | 1995-04-11 | 2000-02-08 | Univ Boston | Streptavidin mutants |
DE19641876B4 (de) | 1996-10-10 | 2011-09-29 | Iba Gmbh | Streptavidinmuteine |
EP0977770A4 (en) | 1997-03-14 | 2000-04-05 | Univ Boston | DIFFERENTLY FLAVORED STREPTAVIDINE |
US5985658A (en) | 1997-11-14 | 1999-11-16 | Health Research Incorporated | Calmodulin-based cell separation technique |
DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
EP1227321A1 (en) | 2000-12-28 | 2002-07-31 | Institut für Bioanalytik GmbH | Reversible MHC multimer staining for functional purification of antigen-specific T cells |
DE10113776B4 (de) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins |
WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
US8076452B2 (en) * | 2002-03-01 | 2011-12-13 | Erdmann Volker A | Streptavidin-binding peptide |
US7754155B2 (en) * | 2002-03-15 | 2010-07-13 | Ross Amelia A | Devices and methods for isolating target cells |
FR2841905B1 (fr) | 2002-07-05 | 2004-09-03 | Centre Nat Rech Scient | Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications |
CN1902491A (zh) * | 2003-11-20 | 2007-01-24 | 瑞典生物传感器应用股份公司 | 至少两种不同的、特异于预定抗原的抗体混合物和该混合物的用途 |
DK1766400T3 (da) * | 2004-06-03 | 2009-07-20 | Meso Scale Technologies Llc | Fremgangsmåde til at udföre fuldblodsanalyser |
GB0422431D0 (en) * | 2004-10-08 | 2004-11-10 | Affitech As | Method |
EP1800136B1 (en) * | 2004-10-15 | 2011-12-07 | Danisco US Inc. | Competitive differential screening |
US20060252087A1 (en) * | 2005-01-18 | 2006-11-09 | Biocept, Inc. | Recovery of rare cells using a microchannel apparatus with patterned posts |
US7855057B2 (en) * | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
US8043822B2 (en) * | 2006-11-02 | 2011-10-25 | Kyowa Medex Co., Ltd. | Method of immunoassaying a component to be measured |
WO2008140573A2 (en) | 2006-11-15 | 2008-11-20 | Invitrogen Dynal As | Methods for reversibly binding a biotin compound to a support |
CN101226118B (zh) * | 2007-01-19 | 2010-06-16 | 中国医学科学院肿瘤研究所 | 一种兼容免疫荧光分析的细胞化学染色方法及其用途 |
JP4962215B2 (ja) | 2007-08-28 | 2012-06-27 | パナソニック株式会社 | 墨出し器の精度確認装置及び墨出し器の精度確認方法 |
SG187453A1 (en) * | 2008-01-18 | 2013-02-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
EP2245142B1 (en) | 2008-01-29 | 2018-03-07 | Fred Hutchinson Cancer Research Center | Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity |
EP2363501A1 (en) | 2010-03-02 | 2011-09-07 | Universitätsklinikum Hamburg-Eppendorf | Method for isolating target cells |
EP2601521B1 (en) * | 2010-08-06 | 2018-05-02 | Ludwig-Maximilians-Universität München | Identification of t cell target antigens |
CN103797028B (zh) | 2011-07-18 | 2017-08-25 | Iba 股份有限公司 | 使靶细胞可逆染色的方法 |
AU2013224027B2 (en) * | 2012-02-23 | 2019-01-24 | Juno Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
EP3132247B1 (en) | 2014-04-16 | 2021-08-18 | Juno Therapeutics GmbH | Methods, kits and apparatus for expanding a population of cells |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
CA3002742A1 (en) | 2015-10-22 | 2017-04-27 | Juno Therapeutics Gmbh | Methods, kits, agents and apparatuses for transduction |
MA45488A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés, kits et appareil de culture de cellules |
-
2013
- 2013-02-25 AU AU2013224027A patent/AU2013224027B2/en active Active
- 2013-02-25 JP JP2014558137A patent/JP6362543B2/ja active Active
- 2013-02-25 EP EP13709791.1A patent/EP2817625A2/en active Pending
- 2013-02-25 WO PCT/EP2013/053650 patent/WO2013124474A2/en active Application Filing
- 2013-02-25 RU RU2014138172A patent/RU2746407C1/ru active
- 2013-02-25 SG SG11201404991YA patent/SG11201404991YA/en unknown
- 2013-02-25 SG SG10201606970UA patent/SG10201606970UA/en unknown
- 2013-02-25 CA CA2865033A patent/CA2865033C/en active Active
- 2013-02-25 CN CN201710137379.4A patent/CN106940268B/zh active Active
- 2013-02-25 US US14/380,699 patent/US10228312B2/en active Active
- 2013-02-25 CN CN201380010911.6A patent/CN104254780B/zh active Active
-
2014
- 2014-08-01 IN IN6475DEN2014 patent/IN2014DN06475A/en unknown
-
2015
- 2015-03-20 HK HK15102849.2A patent/HK1202335A1/zh unknown
-
2018
- 2018-02-28 JP JP2018034273A patent/JP6857626B2/ja active Active
- 2018-12-21 US US16/231,188 patent/US20190226951A1/en active Pending
- 2018-12-21 US US16/231,193 patent/US20190234844A1/en active Pending
-
2019
- 2019-01-11 AU AU2019200178A patent/AU2019200178B2/en active Active
-
2021
- 2021-03-22 JP JP2021046729A patent/JP7192014B2/ja active Active
- 2021-12-08 AU AU2021282451A patent/AU2021282451A1/en active Pending
-
2022
- 2022-12-07 JP JP2022195658A patent/JP2023016981A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US10228312B2 (en) | 2019-03-12 |
RU2746407C1 (ru) | 2021-04-13 |
CN106940268A (zh) | 2017-07-11 |
WO2013124474A3 (en) | 2013-12-05 |
JP6857626B2 (ja) | 2021-04-14 |
AU2013224027B2 (en) | 2019-01-24 |
CN104254780B (zh) | 2017-04-12 |
EP2817625A2 (en) | 2014-12-31 |
JP2015512621A (ja) | 2015-04-30 |
JP2018108103A (ja) | 2018-07-12 |
WO2013124474A2 (en) | 2013-08-29 |
AU2013224027A1 (en) | 2014-10-02 |
JP7192014B2 (ja) | 2022-12-19 |
AU2019200178A1 (en) | 2019-01-31 |
US20150024411A1 (en) | 2015-01-22 |
AU2019200178B2 (en) | 2021-09-09 |
SG11201404991YA (en) | 2014-09-26 |
CN104254780A (zh) | 2014-12-31 |
JP6362543B2 (ja) | 2018-07-25 |
US20190226951A1 (en) | 2019-07-25 |
CA2865033A1 (en) | 2013-08-29 |
SG10201606970UA (en) | 2016-10-28 |
JP2023016981A (ja) | 2023-02-02 |
CN106940268B (zh) | 2021-09-21 |
JP2021090471A (ja) | 2021-06-17 |
IN2014DN06475A (zh) | 2015-06-12 |
US20190234844A1 (en) | 2019-08-01 |
AU2021282451A1 (en) | 2022-01-06 |
CA2865033C (en) | 2021-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1202335A1 (zh) | 細胞和其它複雜生物材料的色譜分離 | |
HK1210494A1 (zh) | 用於細胞培養的裝置和方法 | |
HK1205195A1 (zh) | 抗體及其使用方法 | |
GB201013989D0 (en) | Biological materials and methods of using the same | |
EP2892562A4 (en) | ANTI-MCAM ANTIBODIES AND ASSOCIATED METHOD FOR USE | |
IL238227A0 (en) | Antibodies against c16orf54 and uses thereof | |
EP2912174A4 (en) | METHOD AND MATERIALS FOR ISOLATING NUCLEIC ACID MATERIALS | |
ZA201404675B (en) | Anti-lrp5 antibodies and methods of use | |
EP2742123A4 (en) | ISOLATION AND DETECTION OF CANCER CELLS | |
EP2938632A4 (en) | ANTI-GRANULYSIN ANTIBODIES AND METHODS OF USE | |
EP2748337A4 (en) | CELL SENSITIVITY ASSAY FOR CANCER AND METHODS OF PRODUCTION AND USE THEREOF | |
HK1211627A1 (zh) | 試劑材料和有關的試驗元件 | |
HK1209432A1 (zh) | 抗鋸齒蛋白抗體及使用方法 | |
SG11201502497RA (en) | Sebocyte cell culturing and methods of use | |
SG11201503592TA (en) | Case for containing biological samples and corresponding method of use | |
SG11201406771PA (en) | Stem cell preparations and methods of use | |
GB201215352D0 (en) | Improvements in and relating to the anaalysis of sample | |
AU2012900478A0 (en) | Preservation of Biological Materials | |
GB201112000D0 (en) | Biological materials and uses thereof | |
AU2012901799A0 (en) | Thermo-Electrochemical Cell and Method of Use |